Global Drugs for Malaria Market Insights, Forecast to 2025

Publisher Name :
Date: 08-Mar-2019
No. of pages: 112
Inquire Before Buying

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.

Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.

Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.

The global Drugs for Malaria market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Malaria market based on company, product type, end user and key regions.

This report studies the global market size of Drugs for Malaria in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Malaria in these regions.

This research report categorizes the global Drugs for Malaria market by top players/brands, region, type and end user. This report also studies the global Drugs for Malaria market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Cipla

- Guilin Pharmaceutical

- IPCA Laboratories

- GlaxoSmithKline

- Mylan Labs

- Roche

- Novartis

- Sanofi Aventis

- Ajanta Pharma

Market size by Product

- Aryl Aminoalcohol Compounds

- Antifolate Compounds

- Artemisinin Compounds

Market size by End User

- Prevention

- Treatment

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Drugs for Malaria market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Drugs for Malaria market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Drugs for Malaria companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Drugs for Malaria submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drugs for Malaria are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Malaria market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Drugs for Malaria Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Drugs for Malaria Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drugs for Malaria Market Size Growth Rate by Product
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.4.4 Artemisinin Compounds
1.5 Market by End User
1.5.1 Global Drugs for Malaria Market Size Growth Rate by End User
1.5.2 Prevention
1.5.3 Treatment
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drugs for Malaria Market Size
2.1.1 Global Drugs for Malaria Revenue 2014-2025
2.1.2 Global Drugs for Malaria Sales 2014-2025
2.2 Drugs for Malaria Growth Rate by Regions
2.2.1 Global Drugs for Malaria Sales by Regions
2.2.2 Global Drugs for Malaria Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Drugs for Malaria Sales by Manufacturers
3.1.1 Drugs for Malaria Sales by Manufacturers
3.1.2 Drugs for Malaria Sales Market Share by Manufacturers
3.1.3 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Malaria Revenue by Manufacturers
3.2.1 Drugs for Malaria Revenue by Manufacturers (2014-2019)
3.2.2 Drugs for Malaria Revenue Share by Manufacturers (2014-2019)
3.3 Drugs for Malaria Price by Manufacturers
3.4 Drugs for Malaria Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Malaria Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Malaria Product Type
3.4.3 Date of International Manufacturers Enter into Drugs for Malaria Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Drugs for Malaria Sales by Product
4.2 Global Drugs for Malaria Revenue by Product
4.3 Drugs for Malaria Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Drugs for Malaria Breakdown Data by End User
6 North America
6.1 North America Drugs for Malaria by Countries
6.1.1 North America Drugs for Malaria Sales by Countries
6.1.2 North America Drugs for Malaria Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drugs for Malaria by Product
6.3 North America Drugs for Malaria by End User
7 Europe
7.1 Europe Drugs for Malaria by Countries
7.1.1 Europe Drugs for Malaria Sales by Countries
7.1.2 Europe Drugs for Malaria Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Malaria by Product
7.3 Europe Drugs for Malaria by End User
8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria by Countries
8.1.1 Asia Pacific Drugs for Malaria Sales by Countries
8.1.2 Asia Pacific Drugs for Malaria Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drugs for Malaria by Product
8.3 Asia Pacific Drugs for Malaria by End User
9 Central & South America
9.1 Central & South America Drugs for Malaria by Countries
9.1.1 Central & South America Drugs for Malaria Sales by Countries
9.1.2 Central & South America Drugs for Malaria Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drugs for Malaria by Product
9.3 Central & South America Drugs for Malaria by End User
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Malaria by Countries
10.1.1 Middle East and Africa Drugs for Malaria Sales by Countries
10.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drugs for Malaria by Product
10.3 Middle East and Africa Drugs for Malaria by End User
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Company Details
11.1.2 Company Business Overview
11.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Cipla Drugs for Malaria Products Offered
11.1.5 Cipla Recent Development
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Company Details
11.2.2 Company Business Overview
11.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Guilin Pharmaceutical Drugs for Malaria Products Offered
11.2.5 Guilin Pharmaceutical Recent Development
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.3.4 IPCA Laboratories Drugs for Malaria Products Offered
11.3.5 IPCA Laboratories Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline Drugs for Malaria Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Mylan Labs
11.5.1 Mylan Labs Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Mylan Labs Drugs for Malaria Products Offered
11.5.5 Mylan Labs Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Company Business Overview
11.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Roche Drugs for Malaria Products Offered
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Drugs for Malaria Products Offered
11.7.5 Novartis Recent Development
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Company Details
11.8.2 Company Business Overview
11.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sanofi Aventis Drugs for Malaria Products Offered
11.8.5 Sanofi Aventis Recent Development
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ajanta Pharma Drugs for Malaria Products Offered
11.9.5 Ajanta Pharma Recent Development
12 Future Forecast
12.1 Drugs for Malaria Market Forecast by Regions
12.1.1 Global Drugs for Malaria Sales Forecast by Regions 2019-2025
12.1.2 Global Drugs for Malaria Revenue Forecast by Regions 2019-2025
12.2 Drugs for Malaria Market Forecast by Product
12.2.1 Global Drugs for Malaria Sales Forecast by Product 2019-2025
12.2.2 Global Drugs for Malaria Revenue Forecast by Product 2019-2025
12.3 Drugs for Malaria Market Forecast by End User
12.4 North America Drugs for Malaria Forecast
12.5 Europe Drugs for Malaria Forecast
12.6 Asia Pacific Drugs for Malaria Forecast
12.7 Central & South America Drugs for Malaria Forecast
12.8 Middle East and Africa Drugs for Malaria Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drugs for Malaria Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Drugs for Malaria Product Picture
Table Drugs for Malaria Market Segments
Table Key Manufacturers Drugs for Malaria Covered
Table Global Drugs for Malaria Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Drugs for Malaria Sales Market Share by Product 2014-2025
Figure Aryl Aminoalcohol Compounds Product Picture
Table Major Manufacturers of Aryl Aminoalcohol Compounds
Figure Antifolate Compounds Product Picture
Table Major Manufacturers of Antifolate Compounds
Figure Artemisinin Compounds Product Picture
Table Major Manufacturers of Artemisinin Compounds
Table Global Drugs for Malaria Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Prevention
Figure Treatment
Figure Other
Figure Drugs for Malaria Report Years Considered
Figure Global Drugs for Malaria Market Size 2014-2025 (Million US$)
Figure Global Drugs for Malaria Sales 2014-2025 (K Units)
Table Global Drugs for Malaria Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Drugs for Malaria Sales by Regions 2014-2019 (K Units)
Table Global Drugs for Malaria Sales Market Share by Regions 2014-2019
Figure Global Drugs for Malaria Sales Market Share by Regions 2014-2019
Figure 2018 Global Drugs for Malaria Sales Market Share by Regions
Table Global Drugs for Malaria Revenue by Regions 2014-2019 (Million US$)
Table Global Drugs for Malaria Revenue Market Share by Regions 2014-2019
Figure Global Drugs for Malaria Revenue Market Share by Regions 2014-2019
Figure 2018 Global Drugs for Malaria Revenue Market Share by Regions
Table Global Drugs for Malaria Sales by Manufacturers (2014-2019) (K Units)
Table Global Drugs for Malaria Sales Share by Manufacturers (2014-2019)
Figure Global Drugs for Malaria Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drugs for Malaria Revenue by Manufacturers (2014-2019) (Million USD)
Table Drugs for Malaria Revenue Share by Manufacturers (2014-2019)
Figure Drugs for Malaria Value Share by Manufacturers in 2018
Table Key Manufacturers Drugs for Malaria Price (2014-2019) (USD/Unit)
Table Drugs for Malaria Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drugs for Malaria Product Type
Table Date of International Manufacturers Enter into Drugs for Malaria Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table Global Drugs for Malaria Sales Share by Product (2014-2019)
Figure Global Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure Global Drugs for Malaria Sales Market Share by Product in 2018
Table Global Drugs for Malaria Revenue by Product (2014-2019) (Million US$)
Table Global Drugs for Malaria Revenue Share by Product (2014-2019)
Figure Global Drugs for Malaria Revenue Market Share by Product (2014-2019)
Figure Global Drugs for Malaria Revenue Market Share by Product in 2018
Table Drugs for Malaria Price by Product 2014-2019 (USD/Unit)
Table Global Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table Global Drugs for Malaria Sales Share by End User (2014-2019)
Figure Global Sales Drugs for Malaria Market Share by End User (2014-2019)
Figure Global Sales Drugs for Malaria Market Share by End User in 2018
Figure North America Drugs for Malaria Sales Growth Rate 2014-2019 (K Units)
Figure North America Drugs for Malaria Revenue Growth Rate 2014-2019 (Million US$)
Table North America Drugs for Malaria Sales by Countries (2014-2019) (K Units)
Table North America Drugs for Malaria Sales Market Share by Countries (2014-2019)
Figure 2018 North America Drugs for Malaria Sales Market Share by Countries
Table North America Drugs for Malaria Revenue by Countries (2014-2019) (Million US$)
Table North America Drugs for Malaria Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Drugs for Malaria Revenue Market Share by Countries
Figure United States Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure United States Drugs for Malaria Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Canada Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Table North America Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table North America Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure 2018 North America Drugs for Malaria Market Share by Product
Table North America Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table North America Drugs for Malaria Sales Market Share by End User (2014-2019)
Figure 2018 North America Drugs for Malaria Market Share by End User
Figure Europe Drugs for Malaria Sales Growth Rate 2014-2019 (K Units)
Figure Europe Drugs for Malaria Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Drugs for Malaria Sales by Countries (2014-2019) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Drugs for Malaria Sales Market Share by Countries
Table Europe Drugs for Malaria Revenue by Countries (2014-2019) (Million US$)
Table Europe Drugs for Malaria Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Drugs for Malaria Revenue Market Share by Countries
Figure Germany Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Germany Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure France Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure France Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure UK Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Italy Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Russia Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure 2018 Europe Drugs for Malaria Market Share by Product
Table Europe Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table Europe Drugs for Malaria Sales Market Share by End User (2014-2019)
Figure 2018 Europe Drugs for Malaria Market Share by End User
Figure Asia Pacific Drugs for Malaria Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Drugs for Malaria Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Drugs for Malaria Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drugs for Malaria Sales Market Share by Countries
Table Asia Pacific Drugs for Malaria Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Drugs for Malaria Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drugs for Malaria Revenue Market Share by Countries
Figure China Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure China Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Japan Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Korea Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure India Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure India Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Australia Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Drugs for Malaria Market Share by Product
Table Asia Pacific Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Drugs for Malaria Market Share by End User
Figure Central & South America Drugs for Malaria Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Drugs for Malaria Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Drugs for Malaria Sales by Countries (2014-2019) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drugs for Malaria Sales Market Share by Countries
Table Central & South America Drugs for Malaria Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Drugs for Malaria Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drugs for Malaria Revenue Market Share by Countries
Figure Brazil Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Drugs for Malaria Market Share by Product
Table Central & South America Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Drugs for Malaria Market Share by End User
Figure Middle East and Africa Drugs for Malaria Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Drugs for Malaria Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Drugs for Malaria Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drugs for Malaria Sales Market Share by Countries
Table Middle East and Africa Drugs for Malaria Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Drugs for Malaria Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drugs for Malaria Revenue Market Share by Countries
Figure GCC Countries Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Drugs for Malaria Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Drugs for Malaria Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Drugs for Malaria Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Drugs for Malaria Market Share by Product
Table Middle East and Africa Drugs for Malaria Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Drugs for Malaria Market Share by End User
Table Cipla Company Details
Table Cipla Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Recent Development
Table Guilin Pharmaceutical Company Details
Table Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Guilin Pharmaceutical Recent Development
Table IPCA Laboratories Company Details
Table IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table IPCA Laboratories Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Mylan Labs Company Details
Table Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Labs Recent Development
Table Roche Company Details
Table Roche Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Sanofi Aventis Company Details
Table Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Aventis Recent Development
Table Ajanta Pharma Company Details
Table Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ajanta Pharma Recent Development
Table Global Drugs for Malaria Sales Forecast by Regions 2019-2025 (K Units)
Table Global Drugs for Malaria Sales Market Share Forecast by Regions 2019-2025
Table Global Drugs for Malaria Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Drugs for Malaria Revenue Market Share Forecast by Regions 2019-2025
Table Global Drugs for Malaria Sales Forecast by Product 2019-2025 (K Units)
Table Global Drugs for Malaria Sales Market Share Forecast by Product 2019-2025
Table Global Drugs for Malaria Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Drugs for Malaria Revenue Market Share Forecast by Product 2019-2025
Table Global Drugs for Malaria Sales Forecast by End User 2019-2025 (K Units)
Table Global Drugs for Malaria Sales Market Share Forecast by End User 2019-2025
Figure North America Drugs for Malaria Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Drugs for Malaria Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Drugs for Malaria Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Drugs for Malaria Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Drugs for Malaria Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Drugs for Malaria Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Drugs for Malaria Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Drugs for Malaria Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Drugs for Malaria Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Drugs for Malaria Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Drugs for Malaria Value Chain
Table Drugs for Malaria Customers List
Table Drugs for Malaria Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Drugs for Malaria Market Growth 2020-2025
    Published: 12-Feb-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Drugs for Malaria market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Drugs for Malaria business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by type, appl......
  • Global Dihydroartemisinin Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 12-Feb-2020        Price: US 2980 Onwards        Pages: 88
    Snapshot The global Dihydroartemisinin market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Dihydroartemisinin by product, region and application, in addition, this report introduces market competition situation among the vendors and compan......
  • 2020-2025 Global and Regional Dihydroartemisinin Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report
    Published: 05-Feb-2020        Price: US 3500 Onwards        Pages: 180
    HNY Research projects that the Dihydroartemisinin market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Ltd By Applic......
  • Global Artemisinin Market Growth 2020-2025
    Published: 04-Feb-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Artemisinin market will register a 16.2% CAGR in terms of revenue, the global market size will reach $ 78 million by 2025, from $ 43 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artemisinin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin market by type, application, key man......
  • Global Drugs for Malaria Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 17-Jan-2020        Price: US 3480 Onwards        Pages: 104
    Summary Market Overview The global Drugs for Malaria market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Malaria market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competit......
  • Global Artemisinin Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 16-Jan-2020        Price: US 2980 Onwards        Pages: 83
    Snapshot Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. Because artemisinin itself has physical properties such as poor bioavailability that limit its effectiveness, semisynthetic ......
  • Global Drugs for Malaria Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 13-Jan-2020        Price: US 2980 Onwards        Pages: 95
    Snapshot Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease. The global......
  • Global Drugs for Malaria Market Data Survey Report 2015-2025
    Published: 13-Jan-2020        Price: US 1500 Onwards        Pages: 62
    Summary Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease. The global ......
  • Global Dihydroartemisinin Market Data Survey Report 2015-2025
    Published: 12-Jan-2020        Price: US 1500 Onwards        Pages: 62
    Summary The global Dihydroartemisinin market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs